Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$1B |
| 2 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$539M |
| 3 |
Alibaba
BABA
|
+$476M |
| 4 |
AGN
Allergan plc
AGN
|
+$464M |
| 5 |
Perrigo
PRGO
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$777M |
| 2 |
Merck
MRK
|
+$766M |
| 3 |
AGN
Allergan Inc
AGN
|
+$573M |
| 4 |
SLB Ltd
SLB
|
+$551M |
| 5 |
TJX Companies
TJX
|
+$521M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.12% |
| 2 | Consumer Discretionary | 14.46% |
| 3 | Technology | 12.11% |
| 4 | Communication Services | 11.75% |
| 5 | Financials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
National Grid
NGG
$81.3B
| $5.95M | 0.01% |
87,255
+23,701
| +37% | +$1.65M |
|
|
NVRO
502
DELISTED
NEVRO CORP.
NVRO
| $5.68M | 0.01% |
+146,875
| New | +$4.62M |
|
503
Omeros
OMER
$816M
| $5.39M | 0.01% |
217,371
-40,525
| -16% | -$738K |
|
|
TEP
504
DELISTED
Tallgrass Energy Partners, LP
TEP
| $5.39M | 0.01% |
120,501
+46,500
| +63% | +$1.96M |
|
505
Brunswick
BC
$5.33B
| $5.37M | 0.01% |
104,660
-19,384
| -16% | -$907K |
|
506
Webster Financial
WBS
$12.5B
| $5.32M | 0.01% |
163,606
-12,007
| -7% | -$371K |
|
|
TRNX
507
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $5.23M | ﹤0.01% |
205,021
-225
| -0.1% | -$5.73K |
|
508
ExxonMobil
XOM
$634B
| $5.19M | ﹤0.01% |
56,097
-3,029
| -5% | -$282K |
|
|
STAY
509
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $5.08M | ﹤0.01% |
263,299
+7,708
| +3% | +$156K |
|
|
GNMX
510
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $4.96M | ﹤0.01% |
+981,192
| New | +$4.85M |
|
511
Valley National Bancorp
VLY
$8.01B
| $4.91M | ﹤0.01% |
505,336
+256,896
| +103% | +$2.49M |
|
|
SUNE
512
DELISTED
SUNEDISON, INC COM
SUNE
| $4.85M | ﹤0.01% |
248,377
-5,622
| -2% | -$107K |
|
513
Piper Sandler
PIPR
$5.24B
| $4.5M | ﹤0.01% |
309,596
-30,108
| -9% | -$413K |
|
|
KITE
514
DELISTED
Kite Pharma, Inc.
KITE
| $4.49M | ﹤0.01% |
77,821
-84
| -0.1% | -$3.54K |
|
515
iShares Russell 1000 Growth ETF
IWF
$119B
| $4.44M | ﹤0.01% |
185,584
+109,256
| +143% | +$2.56M |
|
|
FOMX
516
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $4.26M | ﹤0.01% |
607,648
-17,352
| -3% | -$99.3K |
|
|
ADVM
517
DELISTED
Adverum Biotechnologies
ADVM
| $4.22M | ﹤0.01% |
7,823
-2,177
| -22% | -$839K |
|
|
DNR
518
DELISTED
Denbury Resources, Inc.
DNR
| $4.12M | ﹤0.01% |
506,531
-20,318,091
| -98% | -$211M |
|
519
Verastem
VSTM
$547M
| $4.1M | ﹤0.01% |
37,362
-35
| -0.1% | -$3.79K |
|
|
ZSPH
520
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $4.04M | ﹤0.01% |
97,186
-106
| -0.1% | -$4.18K |
|
521
Corning
GLW
$108B
| $4.01M | ﹤0.01% |
+174,736
| New | +$3.56M |
|
|
NTBL
522
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| $3.92M | ﹤0.01% |
+18,937
| New | +$4.09M |
|
523
Huron Consulting
HURN
$1.97B
| $3.92M | ﹤0.01% |
57,245
-210,174
| -79% | -$14.1M |
|
|
LHO
524
DELISTED
LaSalle Hotel Properties
LHO
| $3.84M | ﹤0.01% |
94,837
+16,672
| +21% | +$641K |
|
|
XNPT
525
DELISTED
XENOPORT, INC.
XNPT
| $3.84M | ﹤0.01% |
437,571
-482
| -0.1% | -$3.54K |
|
Similar funds
Jennison Associates's Q4 2014 Portfolio in Review
As of Q4 2014, Jennison Associates held 806 positions worth $107B, down 0.8% from $108B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jennison Associates withdrew a net $3.79B in Q4 2014, closing 91 positions and reducing 351 holdings. Its most notable exit was Oneok, an estimated $184M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Jennison Associates opened a new position in Shire pic worth $1B.
- Jennison Associates's largest Q4 2014 buy was Shire pic: 4,721,078 shares worth $1B.
- Jennison Associates added most to Alibaba in Q4 2014, an estimated $476M increase.
- Jennison Associates's biggest Q4 2014 reduction was Alphabet (Google) Class C, cutting an estimated $777M.
- Jennison Associates fully exited Oneok in Q4 2014, selling an estimated $184M.
- Jennison Associates's ten largest holdings make up 20% of its $107B portfolio in Q4 2014.
- Jennison Associates opened 89 new positions and closed 91 in Q4 2014.
- Jennison Associates's portfolio value fell 0.8% quarter-over-quarter to $107B.
Based on Jennison Associates's 13F filing for Q4 2014, filed 6 Feb 2015.